Resources
CLINICAL PUBLICATIONS
Anxiety
Narayan 2022 Review MC Anxiety
Attitudes
Bawa 2022 Pharmacists Attitudes MC in Aust
Chiu 2022 Aus Cannabis Attitides
Barriers to Use
Erku 2022 Barriers in Australia to MC Use
Cancer Symptoms
Bao 2022 MC Substitutes for Opioids in Cancer
Hardy 2022 CBD for Symptoms in Cancer
Cost Effectiveness
Erku_2021_Cost Effectiveness MMJ Chronic Conditions
Clinical trials
Modaresi 2022 Clinical Trials for MC
Depression
Prescribing and Dosing
Bhjaskar 2021 Consensus Cannabis Dosage
Driving and Impairment
Costales 2023 DUIC Advice Based on Arkell
Blood and oral fluid THC_Impairment_Lambert Initiative_2021
Wickens 2022 DUIC for Rec v Medical
Edibles
Fibromyalgia
Hershkovich 2022 MC for FMyalgia
Headache
Melinyshyn 2022 MC for Headache
Nicholas 2023 MC for Headaches
Hyperemesis
Russo 2021 Cannabis HyperemesisSyndrome
Hypertension
Shah 2023 Hypertension Cannabis
Inflammatory Bowel
Dalavaye 2023 MC for Inflamatory Bowel
Interactions
Graham 2022 Review CBD Interactions
Lungs
Opioids
Bao 2022 MC Substituties for Opioids in Cancer
DeAquino 2022 Review of MC for Withdrawal Opioids
Kudrich 2022 CBD for Withdrawal Opioids
Takakuwa 2021 Reduction in opioids for pain
Overdose
Cano 2022 Review US Overdose Mortality
Pain
bmj_chronic pain guidelines_2021Greis 2021 MMJ for Pain
Takakuwa 2021 Reduction in opioids for pain
Parkinson’s Disease
MedicalMarijuanaand Parkinsons_03.04.22_MJF Foundation
Pregnancy
Real World Evidence
Sakal 2021 Evidence Base T21 MMJ-0001
Schlag 2022 MC Real World Evidence
Safety
MacCallum 2021 MMJ Indications Review
MacCallum 2021 MMJ Cannabis Safety Considerations
Vickery 2022 Australia MC Safety & Benefits
Sleep
TervoClemmens 2023 Cannabis & Sleep
Tervo-Clemmens MC for Sleep Quality
Surgery
surgery guidance cannabis screening
Tobacco
Tourett’s Symdrome
GENERAL LINKS
A primer to medicinal cannabis
Click the title above to download a free copy.
This excellent publication from Bedrocan International discusses the therapeutic use of cannabis – not pot, marijuana, grass, or dope for recreational use to get ‘high’. It focuses strictly on medicinal cannabis and aims to give health care professionals, regulators and patients insights into the medical and scientific aspects of Cannabis sativa L. and how this plant fits in the chain of therapeutic options.
A clinical primer
Click the link above to download a free copy.
This is an excellent guide to the rational use of cannabis-based medicines from Bedrocan International.
Cannabis-based medicines are increasingly being made available on a global level. It is important that prescribers, pharmacists and nurses are equipped with practical, evidence-based guidance to support decision-making, and to improve communication of the benefits and risks of these medicines with their patients. This clinical primer draws on clinical research, clinical observations, and professional experiences to provide useful, real-world insights to the rational use of cannabis-based medicines.
UIC SYMPOSIUM
2022 Saturday 21st May
General Session videos
USEFUL LINKS FOR INDUSTRY
-
TGA – Advertising guidance for businesses involved with medicinal cannabis products
-
TGA – Advertising to health professionals
-
Report non-compliant advertising
-
Office of Drug Control
UIC SYMPOSIUM 2022
Saturday 21st May
Industry Session videos